Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05671185

rTMS for Depressive, Positive and Negative Symptoms, and Physiological Indices of Schizophrenia Patients

Therapeutic Effect of Repetitive Transcranial Magnetic Stimulation for Depressive, Positive and Negative Symptoms, and Physiological Indices of Schizophrenia Patients

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Around 40% of schizophrenia patients present depressive symptoms, which are associated with elevated suicide and violence risk and poor prognosis and quality of life. Recent meta-analysis showed the effect size of antidepressants for depressive symptoms of schizophrenia patients was as low as 0.25, so new therapeutic approach is warranted. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive, anesthesia-free brain stimulation therapy for treatment refractory depression. Currently, rTMS is classified as high-frequency stimulation (\>5Hz, usually 10Hz or 20Hz) and low-frequency inhibition (usually 1Hz). Intermittent theta burst stimulation (iTBS) is a new variant of rTMS, with stimulation frequency as high as 50Hz. Compared with high-frequency rTMS, iTBS has similar therapeutic effect and shorter stimulation duration. Up to now, studies exploring treatment effect of rTMS or iTBS for schizophrenia patients mainly focused on negative symptoms rather than depressive symptoms. Therefore, this study aims to explore treatment effect of rTMS or iTBS of depressive symptoms, negative symptoms, cognitive function and physiological indices for schizophrenia patients.

Conditions

Interventions

TypeNameDescription
DEVICERepetitive Transcranial Magnetic StimulationrTMS using Magstim TMS system is delivered at the left dorsolateral prefrontal cortex

Timeline

Start date
2022-12-01
Primary completion
2028-12-01
Completion
2028-12-01
First posted
2023-01-04
Last updated
2026-01-22

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05671185. Inclusion in this directory is not an endorsement.

rTMS for Depressive, Positive and Negative Symptoms, and Physiological Indices of Schizophrenia Patients (NCT05671185) · Clinical Trials Directory